Neal J. Riley is a digital producer for CBS Boston. He has been with WBZ-TV since 2014. His work has appeared in The Boston Globe and The San Francisco Chronicle. Neal is a graduate of Boston ...

Here’s how to invest in custom visuals and turn that content into years of stronger engagement, trust and brand differentiation. Custom visual content builds trust faster by showing real people, ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Global ...

Apotex Inc., Canada’s largest drug maker, has won Health Canada approval to sell a generic form of the blockbuster Ozempic. The Toronto-based company is the second manufacturer to get an approval, ...

Canada has approved an Indian pharma company’s generic version of the anti-diabetes drug Ozempic, for use in the country. Satish Reddy, managing director and chief operating officer of Dr Reddy's ...

The era of cheap, officially approved semaglutide is finally here—in Canada, that is. The country has just become the first in North America and the first G7 nation to license a generic version of the ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Health Canada ‌ ...

Health Canada has approved the first generic version of brand-name Ozempic. The department says Canada is the first G7 country to authorize generic semaglutide. The injectable medication is ...

Abstract: This study presents a Python-based framework for converting IFC data into RDF triples, ensuring semantic integrity and interoperability in BIM environments. Using the SemanIFC library for ...

What really happens after you hit enter on that AI prompt? WSJ’s Joanna Stern heads inside a data center to trace the journey and then grills up some steaks to show just how much energy it takes to ...

Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established cardiovascular disease or multiple risk factors, and to improve glycemic control ...

At least a dozen large Indian drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs as soon as the patent expires Friday, crashing prices in the country with the ...